RHOB modulators (Inserm Transfert/Evotec)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRHOB modulators (Inserm Transfert/Evotec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-related GTP-binding protein RhoB inhibitors
TargetsRho-related GTP-binding protein RhoB
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm Transfert
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInserm TransfertEvotec SE
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A